Suchergebnisse - "Karakantza, Marina"

PubPharm (85)

1

Apparent changes in RhD status during pregnancy : A case study of weak D variant due to RHD*DAU-2

enthalten in: Transfusion medicine (Oxford, England) | 2024

von Holt, M. | Grimsley, S. | Hazell, M. | +5

2

Apparent changes in RhD status during pregnancy : A case study of weak D variant due to RHD* DAU‐2

enthalten in: Transfusion Medicine | 2024

von Holt, M. | Grimsley, S. | Hazell, M. | +5

3

A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction

enthalten in: EJHaem | 2023

von Chandler, T. | Parrish, C. | Karakantza, M. | +4

4

High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients

enthalten in: Frontiers in medicine | 2022

von Matsagos, S. | Verigou, E. | Kourakli, A. | +11

5

Thrombocytopenia and platelet transfusion in myelodysplastic syndromes

enthalten in: Transfusion | 2020

von Bowen, D. | Karakantza, M.

CommentOn: Transfusion. 2020 Oct;60(10):2192-2198. - PMID 32905635

6

Red cell transfusion in outpatients with myelodysplastic syndromes : a feasibility and exploratory randomised trial

enthalten in: British journal of haematology | 2020

von Stanworth, S. | Killick, S. | McQuilten, Z. | +114

CommentIn: Br J Haematol. 2020 Jun;189(5):813-814. - PMID 32030730

7

Evaluation of the Activity of Neutrophils and Monocytes in Diabetic Patients With Sepsis, Can Surface Antigens HLA-DR and CD64 Be Useful as Prognostic Factors?

enthalten in: Journal of clinical medicine research | 2020

von Lekka, K. | Marangos, M. | Roupas, N. | +3

8

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO) : Construct Validity Study

enthalten in: Frontiers in pharmacology | 2020

von Goswami, P. | Oliva, E. | Ionova, T. | +12

9

Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure : HM-PRO

enthalten in: Frontiers in pharmacology | 2020

von Goswami, P. | Oliva, E. | Ionova, T. | +12

10

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO) : Content Validity

enthalten in: Frontiers in pharmacology | 2020

von Goswami, P. | Oliva, E. | Ionova, T. | +10

1
2
3
4
5
6
7
8
9
Nächster »
[9]